Although other antigens were not significantly different between ET and Pre-PMF patients and between Pre-PMF and Overt-PMF patients, bone marrow granulocyte expression of CD11b, cMPO remained significantly higher in Overt-PMF patients than in ET patients. The gene discussed is ITGAM; the disease is essential thrombocythemia.